![Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days]({"type":"image" , "src" : "/sda/5925/TOC-Subject-Sample-2021-Bioscience.jpg"})
Acknowledgements
The author is grateful to all the test developers who responded to the survey on frequently asked questions, and to Roni Deli-Houssein for his assistance with the development of the www.tbfaqs.org resource.
Disclaimer
The author serves as a consultant to the Bill & Melinda Gates Foundation, but views expressed in the article are his own.
Financial & competing interests disclosure
M Pai receives grant funding (grant OPP1061487) from the Bill & Melinda Gates Foundation for projects to assess the tuberculosis diagnostics market size and develop target product profiles for point-of-care testing. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.
Notes
DST: Drug susceptibility testing; MDR: Multidrug resistant; TB: Tuberculosis; TPP: Target product profile; XDR: Extensively drug-resistant.